Studying NMDA and Sigma-1 in Smoking Cessation Treatment (SUMMIT)

计划入组 705 人 · 首次发布于 2026 年 8 月 14 日

Dual Modulation of Sigma-1 and NMDA Receptors in the Treatment of Schizophrenia

计划入组 90 人 · 首次发布于 2024 年 8 月 27 日

Novel Clinical Target in Fragile X Syndrome

首次发布于 2020 年 3 月 19 日

sigma-1 inhibitors (Context)

sigma-1 receptor antagonists

TXT-0100

Millipore Sigma

United States

NHI-1

United States

SIGMA COMPANY LIMITED

Australia

Tonix Pharmaceuticals Licenses TNX-4900, Novel Sigma-1 Receptor Antagonist for Chronic Neuropathic Pain

DMT Shows Neuroprotective Effects in Stroke Through Blood-Brain Barrier Stabilization and Anti-Inflammatory Action

Luye Pharma Launches Phase II Trial of LY03015 for Tardive Dyskinesia and Huntington's Disease